- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
E-Z-EM appoints executive for Asia
With a view to taking advantage of the imaging business in Japan, China, and the Pacific Rim, E-Z-EM has appointed Michael Dellario managing director for Asia. Dellario will assume responsibility for the company’s subsidiary, Toho Kagaku Kenkyusho.
With a view to taking advantage of the imaging business in Japan, China, and the Pacific Rim, E-Z-EM has appointed Michael Dellario managing director for Asia. Dellario will assume responsibility for the company’s subsidiary, Toho Kagaku Kenkyusho. He is charged with reorganizing Toho from a manufacturing-based organization to a sales and marketing group. Dellario began his career with AngioDynamics, a subsidiary of E-Z-EM, where he was director of marketing for various cardiology and interventional radiology product groups. In 1999, he joined E-Z-EM’s international operations department as sales and marketing director in Asia for both E-Z-EM and AngioDynamics.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.
